Skip to content
Agree.net – Lifestyle
Author:
Martin Guijarro
Innovent to Present New Clinical Data of IBI363（PD-1/IL-2α-biased bispecific fusion protein） at the 2026 ASCO Annual Meeting
April 25, 2026
Cialfir Group Enters the U.S. Market Under the Strategic Guidance of Martín Guijarro
March 6, 2026
Building Bridges of Fire; How Martín Guijarro Connects Europe and the U.S. Pyrotechnics Markets
March 4, 2026